PharmaBridge
The AI market-entry copilot for Chinese pharmaceutical and health-science startups expanding into the US, UK, EU, and Canada.
Chinese pharma startups may have strong products, but Western expansion is difficult because of regulatory confusion, risky medical claims, weak localization, labeling issues, investor mistrust, and unclear partner strategy. PharmaBridge changes that.
Turn product information into a regulatory roadmap, compliance risk report, localized marketing copy, and partner outreach plan — in minutes.
Western Market Entry Is Complex
Chinese pharmaceutical and health-science startups face significant barriers when entering Western markets. Without proper guidance, costly mistakes are common.
Regulatory Uncertainty
Complex, market-specific regulations that differ significantly from Chinese requirements
Risky Product Claims
Marketing language that may trigger medicinal classification or enforcement action
Non-Compliant Labels
Missing warnings, unclear dosage, and translation issues that erode trust
Weak Western-Facing Materials
Pitch decks and product summaries that don't resonate with Western investors
No Partner Strategy
Lack of clear distributor, clinical, or investor engagement plan
Cultural Mistrust
Western buyers and investors may be skeptical without proper positioning
73%
of Chinese pharma startups face regulatory delays in Western markets
Your Complete Western Expansion Package
PharmaBridge creates everything you need for confident Western market entry — from regulatory roadmaps to partner outreach emails.
Regulatory Roadmap
Identify the likely regulatory pathway, required documents, missing evidence, and next steps for your target market.
Claim Risk Analysis
Detect risky medical claims, overpromising language, and unsupported promises in your marketing copy.
Safer English Copy
Rewrite your marketing language into compliant, Western-facing English that builds trust.
Label & Packaging Review
Review label text for missing warnings, unclear dosage, translation issues, and compliance gaps.
Investor Trust Materials
Generate investor one-liners, distributor pitches, FAQs, and risk disclosures.
Partner Outreach Strategy
Get recommended partner types, outreach angles, and a professional outreach email.
Five AI-Powered Modules
Each module addresses a critical aspect of Western market entry, powered by intelligent analysis.
Regulatory Roadmap AI
Identifies the likely regulatory pathway, required documents, missing evidence, and recommended next steps for your specific product and target market.
ClaimGuard AI
Detects risky medical claims, overpromising language, unsupported promises, and rewrites claims into safer Western-facing wording that maintains marketing effectiveness.
LabelBridge AI
Reviews label and packaging text for unclear dosage instructions, missing warnings, translation issues, and trust problems that could delay market entry.
TrustPack AI
Creates investor and distributor-facing materials including product summaries, FAQs, risk disclosures, and positioning language tailored to Western expectations.
PartnerMatch AI
Suggests optimal partner types, distributor profiles, clinical and research partners, investor categories, and outreach angles for your target market.
From Product Details to Market-Ready Report
Enter Product Details
Company name, product info, ingredients, and regulatory status
Select Target Market
Choose US, UK, EU, or Canada as your expansion target
Paste Marketing Copy
Add your current label text and marketing claims
Generate Report
AI analyzes your product and creates a comprehensive report
Export & Act
Use the report for investor, distributor, or regulatory preparation
See It in Action
A Chinese herbal anti-inflammatory capsule wants to enter the UK market. Here is what PharmaBridge finds:
Market Readiness Score
Key Findings
Medical claims are too aggressive for UK market
"Cures inflammation" is a high-risk curative claim
"Supports joint comfort and general wellness"